Prothena Corporation News

News

Ticker

PRTA

ISIN

IE00B91XRN20

Chiffre d'affaires Résultat net P/E P/S EBIT Dividende Achats de membres du conseil Actions Capitalisation boursière Endettement Passifs Capitaux propres AAQS Effectifs ROE ROA ROCE News Documents

Actualités Eulerpool Prothena Corporation

16/06/2025 10:00:43

Roche plant Phase-III-Studie für innovativen Parkinson-Wirkstoff

19/12/2024 16:10:53

Studienergebnisse zu Prasinezumab bei Parkinson: Ein Lichtblick mit Einschränkungen

Actualités de l'action Prothena Corporation

Prothena Corporation est suivi par de nombreux journalistes et investisseurs dans le monde. Nous rassemblons ici les dernières actualités concernant Prothena Corporation.

9 mars·
Yahoo
Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy
3 mars·
Yahoo
Wall Street Analysts Believe Prothena (PRTA) Could Rally 118.09%: Here's is How to Trade
3 mars·
SeekingAlpha
Prothena: A Hold With 2 Late-Stage Programs Underway But With Caution
27 février·
Yahoo
Prothena Announces up to $100 Million Share Repurchase Plan
27 février·
Benzinga
Prothena shares are trading higher after the company announced a $100 million share buyback.
27 février·
Benzinga
Prothena Announces $100M Share Buyback
20 février·
Yahoo
Prothena Q4 Earnings Meet Estimates, Pipeline Progress in Focus
20 février·
Yahoo
Prothena Corporation plc Q4 2025 Earnings Call Summary
20 février·
Benzinga
RBC Capital Maintains Sector Perform on Prothena Corp, Raises Price Target to $12
20 février·
SeekingAlpha
Prothena Corporation plc 2025 Q4 - Results - Earnings Call Presentation
20 février·
Yahoo
Prothena Corp PLC (PRTA) Q4 2025 Earnings Call Highlights: Strategic Advancements and Financial ...
20 février·
Yahoo
Prothena Q4 Earnings Call Highlights
20 février·
ChartMill
Prothena Corporation (NASDAQ:PRTA) Reports Q4 2025 Revenue Miss, Highlights Pipeline Progress and 2026 Cash Guidance
19 février·
Yahoo
Prothena (PRTA) Reports Q4 Loss, Lags Revenue Estimates
19 février·
Yahoo
Prothena: Q4 Earnings Snapshot
19 février·
SeekingAlpha
Prothena Corporation plc (PRTA) Q4 2025 Earnings Call Transcript
19 février·
Yahoo
Prothena Reports Fourth Quarter and Full Year 2025 Financial Results, and Provides Financial Guidance and Business Highlights
19 février·
Benzinga
Prothena Corp Q4 Earnings Assessment
19 février·
Benzinga
Prothena Corp Q4 EPS $(0.40) Beats $(0.54) Estimate, Sales $21.000K Miss $1.334M Estimate
19 février·
Benzinga
Earnings Scheduled For February 19, 2026

Communiqués de presse relatifs à l'action Prothena Corporation

Prothena Corporation publie régulièrement sur son site web des communiqués pertinents pour les investisseurs.

14 décembre•
Prothena Corporation
Prothena Announces Pricing of Public Offering of 3,250,000 Ordinary Shares
13 décembre•
Prothena Corporation
Prothena Announces Proposed Public Offering of Ordinary Shares
12 décembre•
Prothena Corporation
Prothena Presents Data Demonstrating Consistent Survival Benefit Observed with Birtamimab in Mayo Stage IV AL Amyloidosis Patients in Phase 3 VITAL Study at ASH 2022
21 novembre•
Prothena Corporation
Prothena Announces Achievement of $40 Million Clinical Milestone Payment from Novo Nordisk for PRX004/NNC6019 Under Investigation for the Treatment of ATTR Cardiomyopathy
3 novembre•
Prothena Corporation
Prothena Reports Third Quarter 2022 Financial Results and Business Highlights
3 novembre•
Prothena Corporation
Prothena to Present Data on Survival Benefit Observed in Completed Phase 3 Study of Drug Candidate Birtamimab in Patients with Mayo Stage IV AL Amyloidosis at the ASH 2022 Meeting
27 octobre•
Prothena Corporation
Prothena to Report Third Quarter 2022 Financial Results on November 3rd
1 septembre•
Prothena Corporation
Prothena to Participate in Upcoming Healthcare Conferences
1 septembre•
Prothena Corporation
Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors
8 août•
Prothena Corporation
Prothena Reports Second Quarter 2022 Financial Results and Business Highlights
2 août•
Prothena Corporation
Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1 août•
Prothena Corporation
Prothena to Report Second Quarter 2022 Financial Results on August 8th
1 juillet•
Prothena Corporation
Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2 juin•
Prothena Corporation
Prothena to Participate in Jefferies Healthcare Conference
5 mai•
Prothena Corporation
Prothena Reports First Quarter 2022 Financial Results and Business Highlights
28 avril•
Prothena Corporation
Prothena to Report First Quarter 2022 Financial Results on May 5th
26 avril•
Prothena Corporation
Prothena Receives FDA Fast Track Designation for PRX012, a Next-Generation Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease
28 mars•
Prothena Corporation
Prothena Announces FDA Clearance of IND for PRX012, a Subcutaneous Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease
21 mars•
Prothena Corporation
Prothena to Participate in Stifel 2022 Virtual CNS Days
16 mars•
Prothena Corporation
Prothena Presents New Data for Alzheimer’s and Parkinson’s Disease Programs at AD/PD 2022
17 février•
Prothena Corporation
Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidance and Business Highlights
10 février•
Prothena Corporation
Prothena to Report Fourth Quarter and Full Year 2021 Financial Results and Host Webcast Conference Call on February 17, 2022
29 novembre•
Prothena Corporation
Prothena to Participate in JMP Securities Hematology and Oncology Summit
4 novembre•
Prothena Corporation
Prothena Reports Third Quarter 2021 Financial Results and Business Highlights
1 octobre•
Prothena Corporation
Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1 octobre•
Prothena Corporation
Prothena Announces Executive Appointments
3 septembre•
Prothena Corporation
Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
1 septembre•
Prothena Corporation
Prothena to Participate in Upcoming September Healthcare Conferences
5 août•
Prothena Corporation
Prothena Reports Second Quarter 2021 Financial Results and Business Highlights
29 juillet•
Prothena Corporation
Prothena to Report Second Quarter 2021 Financial Results on August 5th

Prothena Corporation News 2026

Cette page contient toutes les actualités actuelles, analyses et communiqués de presse pour l'action Prothena Corporation (PRTA, ISIN : IE00B91XRN20). Cela inclut les actualités Eulerpool, les analyses d'entreprise et les communiqués de presse officiels. Les données sont mises à jour régulièrement pour fournir aux investisseurs un aperçu complet des derniers développements chez Prothena Corporation.

Prothena Corporation Action

Prothena Corporation Prothena Corporation PLC est une entreprise biopharmaceutique basée à Dublin, en Irlande, spécialisée dans le développement de thérapies contre les maladies protéiques. La société a été créée en 2012 en tant que spin-off du département de recherche de la société Elan Corporation et est cotée au NASDAQ depuis 2014.